14-28767779-AG-AGG
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005249.5(FOXG1):c.506dupG(p.Lys170GlnfsTer285) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005249.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXG1 | ENST00000313071.7 | c.506dupG | p.Lys170GlnfsTer285 | frameshift_variant | Exon 1 of 1 | 6 | NM_005249.5 | ENSP00000339004.3 | ||
FOXG1 | ENST00000706482.1 | c.506dupG | p.Lys170GlnfsTer285 | frameshift_variant | Exon 2 of 2 | ENSP00000516406.1 | ||||
LINC01551 | ENST00000675861.1 | n.374+1772dupG | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.506dupG variant in the FOXG1 gene has been reported previously as presumed de novo in an individual with severe developmental delay, intellectual disability, acquired microcephaly, trigonocephaly, abnormal brain MRI, and infantile spasms (De Bruyn et al., 2014). The c.506dupG variant causes a frameshift starting with codon Lysine 170, changes this amino acid to a Glutamine residue, and creates a premature Stop codon at position 285 of the new reading frame, denoted p.Lys170GlnfsX285. This variant is predicted to cause loss of normal protein function through protein truncation. The c.506dupG variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.506dupG as a pathogenic variant. -
FOXG1 disorder Pathogenic:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as Pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant has been identified as a de novo occurrence in an individual with FOXG1 disorder without confirmation of paternity and maternity (PM6, PMID: 24388699). This variant is absent from gnomAD (PM2_Supporting). -
Rett syndrome, congenital variant Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at